Literature DB >> 6456689

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.

P C Fuchs, A L Barry, C Thornsberry, R N Jones, E H Gerlack.   

Abstract

The susceptibility of 447 clinical bacterial isolates to mezlocillin and carbenicillin was tested by standardized agar disk diffusion and reference broth micro-dilution methods. Tentative interpretive criteria for disk susceptibility testing by using 75 micrograms mezlocillin disks are proposed: susceptible, greater than or equal to 16 mm; indeterminate, 13 to 15 mm; and resistant, less than or equal to 12 mm. These would be applicable to both Pseudomonas species and the Enterobacteriaceae, but not to Staphylococcus aureus. For S. aureus, the breakpoints for susceptible, greater than or equal to 29 mm, and resistant, less than or equal to 28 mm, hold for mezlocillin as well as for the other penicillinase-susceptible penicillins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456689      PMCID: PMC181663          DOI: 10.1128/AAC.20.2.197

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

2.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

3.  Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.

Authors:  P C Fuchs; C Thornsberry; A L Barry; T L Gavan; E H Gerlach; R N Jones
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

4.  Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.

Authors:  G W White; J B Malow; V M Zimelis; H Pahlavanzadeh; A P Panwalker; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

5.  Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.

Authors:  M F Parry; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

8.  Kinetics of mezlocillin and carbenicillin.

Authors:  S J Pancoast; H C Neu
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

9.  Clinical pharmacology of mezlocillin.

Authors:  B F Issell; G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

View more
  1 in total

1.  Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.

Authors:  H Grimm
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.